specific binding member, pharmaceutical composition, method for treating a tumor in a patient, use of a binding member, products, nucleic acid, and sialyl tetraosyl carbohydrate

摘要

SPECIFIC LINKING MEMBER, PHARMACEUTICAL COMPOSITION, METHOD FOR TREATMENT OF A TUMOR IN A PATIENT, USE OF A LINKING MEMBER, PRODUCTS, NUCLEIC ACID, AND, SIALILTETRAOSILAL CARBIDRATE OF A SPECIFIC BINDING OF ANY MEMBERSHIP sialiltetraosyl carbohydrate and directly induce cell death without the need for immune effector cells. This binding member may be an antibody or a part thereof. Also provided are the use of these binding members in medicine and nucleic acids encoding these binding members.